HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Alcohol abuse: epidemiological, pathophysiological, therapeutic aspects and prevention strategies

DOI: https://doi.org/10.29296/25877305-2021-04-02

Professor K. Amlaev, MD Stavropol State Medical University

The article deals with the problem of alcohol abuse from the perspective of medical prevention. The relevance of this problem is due to the wide spread of 283 million people. in a world with high mortality and negative social consequences. Modern classification of disorders in accordance with ICD-11 is given, pathophysiological mechanisms of alcoholism formation are considered, risk groups and negative consequences of chronic alcohol use are described. Measures to prevent alcoholism, including those implemented at the state level, are described.

medical prevention of alcoholism

  1. Molina P.E., Nelson S. Binge Drinking’s Effects on the Body. Alcohol Res. 2018; 39 (1): 99–109.
  2. Global status report on alcohol and health. WHO. 2018. URL: https://apps.who.int/iris/bitstream/handle/10665/274603/9789241565639-eng.pdf?ua=1
  3. Rehm J., Imtiaz S. A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst Abuse Treat Prev Policy. 20168; 11 (1): 37. DOI: 10.1186/s13011-016-0081-2
  4. Sebastiani G., Borrás-Novell C., Alsina M. et al. The Effects of Alcohol and Drugs of Abuse on Maternal Nutritional Profile during Pregnancy. Nutrients. 2018; 10 (8): 1008. DOI: 10.3390/nu10081008.
  5. Kendler K.S., Edwards A., Myers J. et al. The predictive power of family history measures of alcohol and drug problems and internalizing disorders in a college population. Am J Med Genet B Neuropsychiatr Genet. 2015; 168B (5): 337–46. DOI: 10.1002/ajmg.b.32320.
  6. Delker E., Brown Q., Hasin D. Alcohol Consumption in Demographic Subpopulations: An Epidemiologic Overview. Alcohol Res Curr Rev. 2016; 38: 7–14.
  7. Windle M. Drinking Over the Lifespan: Focus on Early Adolescents and Youth. Alcohol Res. 2016; 38 (1): 95–101.
  8. Grigsby T.J., Forster M., Unger J.B. et al. Predictors of alcohol-related negative consequences in adolescents: A systematic review of the literature and implications for future research. J Adolesc. 2016; 48: 18–35. DOI: 10.1016/j.adolescence.2016.01.006
  9. Abrahao K.P., Salinas A.G., Lovinger D.M. Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits. Neuron. 2017; 96 (6): 1223–38. DOI: 10.1016/j.neuron.2017.10.032
  10. Edenberg H.J., McClintick J.N. Alcohol Dehydrogenases, Aldehyde Dehydrogenases, and Alcohol Use Disorders: A Critical Review. Alcohol Clin Exp Res. 2018; 42 (12): 2281–97. DOI: 10.1111/acer.13904
  11. Costardi J.V., Nampo R.A., Silva G.L. et al. A review on alcohol: from the central action mechanism to chemical dependency. Rev Assoc Med Bras (1992). 2015; 61 (4): 381–7. DOI: 10.1590/1806-9282.61.04.381
  12. Howard C. Becker Influence of Stress Associated with Chronic Alcohol Exposure on Drinking. Neuropharmacology. 2017; 122: 115–26. DOI: 10.1016/j.neuropharm.2017.04.028
  13. Patel S., Behara R., Swanson G.R. et al. Alcohol and the Intestine. Biomolecules. 2015; 5 (4): 2573–88. DOI: 10.3390/biom5042573
  14. Campollo O. Alcohol and the Liver: The Return of the Prodigal Son. Ann Hepatol. 2019; 18 (1): 6–10. DOI: 10.5604/01.3001.0012.7854
  15. Roerecke M., Kaczorowski J., Tobe S.W. et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017; 2 (2): e108–e120. DOI: 10.1016/S2468-2667(17)30003-8
  16. McHugh R.K., Weiss R.D. Alcohol Use Disorder and Depressive Disorders. Alcohol Res. 2019; 40 (1): arcr.v40.1.01. DOI: 10.35946/arcr.v40.1.01
  17. Borges G., Bagge C.L., Cherpitel C.J. et al. A meta-analysis of acute use of alcohol and the risk of suicide attempt. Psychol Med. 2017; 47 (5): 949–57. DOI: 10.1017/S0033291716002841
  18. Cannella N., Ubaldi M., Masi A. et al. Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neurosci Biobehav Rev. 2019; 103: 384–98. DOI: 10.1016/j.neubiorev.2019.05.014
  19. Kukushkin A.V. Primenenie fitopreparata «Nervo-Vit» v lechenii patsientov s psihovegetativnym sindromom. Poliklinika. 2017; 1–1: 29–32 [Kukushkin A.V. Primenenie fitopreparata «Nervo-Vit» v lechenii patsientov s psikhovegetativnym sindromom. Poliklinika. 2017; 1–1: 29–32 (in Russ.)].
  20. Petrova E.V., Polubojarinov P.A., Strukov V.I. i dr. Fitopreparat «Nervo-Vit» kak al'ternativa sinteticheskim trankvilizatoram. V sb.: Sovremennye problemy fitoterapii i travnichestva. Mat-ly 5-go mezhdunar. s'ezda fitoterapevtov i travnikov, posvjasch. 100-letiju patriarha otechestvennoj fitoterapii K.A. Treskunova, Chernogolovka, 28–29 janvarja 2019 g. M.: Russkie, 2019 [Petrova E.V., Poluboyarinov P.A., Strukov V.I. et al. Fitopreparat «Nervo-Vit» kak al’ternativa sinteticheskim trankvilizatoram. V sb.: Sovremennye problemy fitoterapii i travnichestva. Mat-ly 5-go mezhdunar. s»ezda fitoterapevtov i travnikov, posvyashch. 100-letiyu patriarkha otechestvennoi fitoterapii K.A. Treskunova, Chernogolovka, 28–29 yanvarya 2019 g. M.: Russkie, 2019 (in Russ.)].
  21. Sejfulla R., Potupchik T., Polubojarinov P. i dr. Vozmozhnosti primenenija kombinirovannogo adaptogena Leveton P. Vrach. 2018; 29 (10): 37–44 [Seifulla R., Potupchik T., Poluboyarinov P. et al. Possibilities of using the combined adaptogen Leveton P. Vrach. 2018; 29 (10): 37–44 (in Russ.)]. DOI: 10.29296/25877305-2018-10-10
  22. Knox J., Hasin D.S., Larson F.R.R. et al. Prevention, screening, and treatment for heavy drinking and alcohol use disorder. Lancet Psychiatry. 2019; 6 (12): 1054–67. DOI: 10.1016/S2215-0366(19)30213-5
  23. Mason B.J. Emerging pharmacotherapies for alcohol use disorder. Neuropharmacology. 2017; 122: 244–53. DOI: 10.1016/j.neuropharm.2017.04.032
  24. Pradhan A.M., Park L., Shaya F.T. et al. Consumer Health Information Technology in the Prevention of Substance Abuse: Scoping Review. J Med Internet Res. 2019; 21 (1): e11297. DOI: 10.2196/11297
  25. Gomes T.B., Vecchia M.D. Harm reduction strategies regarding the misuse of alcohol and other drugs: a review of the literature. Cien Saude Colet. 2018; 23 (7): 2327–38. DOI: 10.1590/1413-81232018237.21152016
  26. Suffoletto B., Scaglione S. Using Digital Interventions to Support Individuals with Alcohol Use Disorder and Advanced Liver Disease: A Bridge Over Troubled Waters. Alcohol Clin Exp Res. 2018; 42 (7): 1160–5. DOI: 10.1111/acer.13771
  27. Derges J., Kidger J., Fox F. et al. Alcohol screening and brief interventions for adults and young people in health and community-based settings: a qualitative systematic literature review. BMC Public Health. 2017; 17 (1): 562. DOI: 10.1186/s12889-017-4476-4
  28. Burton R., Henn C., Lavoie D. et al. A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective. Lancet. 2017; 389 (10078): 1558–80. DOI: 10.1016/S0140-6736(16)32420-5
  29. Smyshljaev A.V., Mel'nikov Ju.Ju., Evdakov V.A. Organizatsionnye aspekty profilaktiki zloupotreblenija alkogolem. Sovremennye problemy zdravoohranenija i meditsinskoj statistiki. 2017; 3: 52–61 [Smyshlyaev A.V., Melnikov Y.Y., Evdakov V.A. Issues in the management of the prevention of alcohol addiction. Current problems of health care and medical statistics. 2017; 3: 52–61 (in Russ.)].